Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 USD | 0.00% | 0.00% | -68.52% |
10/04 | SeqLL Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | SeqLL Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Quotes 5-day view
Delayed Quote OTC Markets25/04/2024 | 26/04/2024 | 02/05/2024 | |
---|---|---|---|
Last | 1.3 $ | 1.3 $ | 1.3 $ |
Volume | 374 | 102 | 193 |
Change | +∞% | 0.00% | 0.00% |
Opening | 1.30 | 1.30 | 1.30 |
High | 1.30 | 1.30 | 1.30 |
Low | 1.30 | 1.30 | 1.30 |
Performance
1 month | -36.59% | ||
3 months | -67.50% | ||
6 months | -87.71% | ||
Current year | -68.52% | ||
1 year | -92.36% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Advanced Medical Equipment & Technology
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
0.00% | 0.00% | -68.52% | -92.36% | 495K | ||
+0.20% | -0.21% | +7.84% | +4.90% | 218B | ||
+0.61% | +0.71% | +7.35% | +2.48% | 184B | ||
+0.98% | +1.61% | +13.04% | +25.77% | 135B | ||
+1.37% | -1.96% | -1.33% | -9.55% | 62.38B | ||
+0.22% | -1.37% | +11.80% | -3.01% | 51.37B | ||
+0.82% | +5.47% | +4.81% | -3.30% | 50.9B | ||
+1.40% | +1.24% | +0.30% | +4.16% | 40.87B | ||
+2.11% | -7.85% | +2.78% | +1.55% | 36.28B | ||
-0.54% | -0.50% | +26.14% | -6.51% | 31.88B | ||
+0.08% | +26.82% | +18.76% | +38.49% | 24.39B | ||
+1.80% | +3.20% | -2.42% | +8.53% | 19.05B | ||
-4.89% | -3.56% | -15.30% | -39.92% | 18.78B | ||
+0.83% | +0.74% | +7.12% | -7.17% | 17.86B | ||
+2.97% | +3.75% | +10.56% | -7.64% | 17.2B | ||
-0.46% | -0.89% | -7.96% | -23.27% | 12.43B | ||
Average | +0.47% | +1.73% | +0.94% | -6.68% | ||
Weighted average by Cap. | +0.60% | +0.98% | +7.47% | +4.25% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -68.52% | ||
2023 | -64.48% | ||
2022 | -84.45% | ||
2021 | -58.81% |
- Stock Market
- Equities
- SEQL Stock
- Quotes SeqLL Inc.